Gracell Biotech launches $159m US IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Gracell Biotech launches $159m US IPO

Jonathan Breen
January 05, 2021 08:30 AM
Biotech_Adobe_575x375_Oct21

Chinese clinical-stage company Gracell Biotechnologies has kicked off the roadshow for its Nasdaq listing, eyeing up to $158.9m in proceeds.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechEquityChinaAmericasCitiJefferies LLCAsiaGreater ChinaNortheast AsiaAsia PacificWells Fargo SecuritiesUnited StatesEmerging MarketsNorth AmericaSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article